Epilepsy affects an estimated 3.4 million Americans, with about 150,000 new diagnoses each year, and incidence is bimodal, peaking in early childhood and again after age 60, when adults 65 and older have the highest age-specific incidence of any group. In this population, new-onset seizures are often linked to stroke, neurodegenerative disease, or other structural brain pathology, and seizures carry a high burden of falls, injury, hospitalization, and loss of independence. Distinguishing a provoked seizure from a single unprovoked event or established epilepsy, and documenting that distinction precisely, is among the highest-value clinical actions a primary care team can take.
AAVBC's Seizure Disorders Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across epilepsy type, intractability, and status epilepticus, HCC/RAF V28 mapping, diagnostic thresholds and status epilepticus staging, MEAT documentation standards, guideline-aligned antiseizure medication selection by seizure type, medications that lower seizure threshold, comorbidity management, and referral and follow-up timing. Grounded in ILAE-aligned diagnostic criteria and current treatment guidance, this guide supports consistent, individualized clinical decision-making, helping care teams distinguish provoked seizures from established epilepsy and document that distinction completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of seizure disorders — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Epilepsy affects an estimated 3.4 million Americans, with about 150,000 new diagnoses each year, and incidence is bimodal, peaking in early childhood and again after age 60, when adults 65 and older have the highest age-specific incidence of any group. In this population, new-onset seizures are often linked to stroke, neurodegenerative disease, or other structural brain pathology, and seizures carry a high burden of falls, injury, hospitalization, and loss of independence. Distinguishing a provoked seizure from a single unprovoked event or established epilepsy, and documenting that distinction precisely, is among the highest-value clinical actions a primary care team can take.
AAVBC's Seizure Disorders Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across epilepsy type, intractability, and status epilepticus, HCC/RAF V28 mapping, diagnostic thresholds and status epilepticus staging, MEAT documentation standards, guideline-aligned antiseizure medication selection by seizure type, medications that lower seizure threshold, comorbidity management, and referral and follow-up timing. Grounded in ILAE-aligned diagnostic criteria and current treatment guidance, this guide supports consistent, individualized clinical decision-making, helping care teams distinguish provoked seizures from established epilepsy and document that distinction completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of seizure disorders — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
